SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-090814
Filing Date
2013-03-05
Accepted
2013-03-05 09:06:02
Documents
4
Period of Report
2013-03-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d498361d8k.htm 8-K 15947
2 EX-5.1 d498361dex51.htm EX-5.1 7961
3 EX-99.1 d498361dex991.htm EX-99.1 7702
4 GRAPHIC g498361arca.jpg GRAPHIC 5225
  Complete submission text file 0001193125-13-090814.txt   40299
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 13663973
SIC: 2835 In Vitro & In Vivo Diagnostic Substances